-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-510616-73-00
5
2020-12-16
newly diagnosed WHO grade 2 or 3 glioma
-
2024-514892-16-00
6
2020-05-05
Diarrhoea predominant irritable bowel syndrome
-
2024-512104-19-00
6
2019-11-19
Irritable Bowel Syndrome
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2024-518811-20-00
4
2025-09-30
Early-Stage, PIK3CA-Mutated Breast Cancer (BC)
-
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
-
2023-506880-32-01
1
2025-04-14
Pulmonary Disease, Chronic Obstructive
-
2023-508932-68-00
4
2024-11-14
Diabetic Peripheral Neuropathic Pain
-
2023-503383-17-01
5
2024-10-10
Female androgenetic alopecia
-
2022-501172-25-00
5
2024-01-17
Chronic and Episodic Migraine
-
2022-501576-25-00
5
2023-07-07
Melanoma
-
2023-508462-15-00
10
2023-04-27
Narcolepsy with Cataplexy (Narcolepsy Type 1)
-
2023-505772-30-00
5
2022-11-09
Melanoma
-
2022-502122-41-00
5
2021-05-11
Clear cell renal cancer
-
2023-507582-25-00
5
2019-08-02
Malignant Extracranial Germ Cell Tumours (MGCT)
-
2023-509856-32-00
5
2018-07-15
acute lymphoblastic leukemia in children and adolescents
-
2024-513070-21-00
4
2018-02-15
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
-
2023-505509-18-00
5
2017-07-12
mature aggressive B-cell lymphoma and leukemia in children and adolesc
-
2022-502903-31-00
5
2025-11-05
Patients with ADHD (according to ICD-10 / DSM-5)